Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
1,137
currently held
Exits tracked
410
hand-checked
Sectors covered
1
across the portfolio
Countries covered
38
from every market
Latest activity
HgCapital Trust4 days ago

New Director · Appointment of ALI, Moynul as director · New director appointed · board evolution

admin
Treble Peak5 days ago

Share Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal

capital

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Board change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board

admin

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
1,419 companies matching · Page 25 of 29
Frema
Erganeo
France
Active
Sector
Biotech
InvestorErganeo
Entry
2020
Hold
6yr
FutuRx
Leaps by Bayer
Israel
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Galilei Biosciences
Apollo Health Ventures Fund II
United States
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2021
Hold
5yr
GAMAMABS
BioDiscovery 4
France
Active
Sector
Biotech
InvestorAndera Partners
Entry
2015
Hold
11yr
Gastrotech Pharma
Nordic Biotech K/S
Denmark
Active
Sector
Biotech
InvestorNordic Biotech Advisors
Entry
2003
Hold
23yr
GC Therapeutics
Mubadala Capital Other Investments
USA
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Gedea Biotech
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2017
Hold
9yr
Genagon Theraputics AB
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2015
Hold
11yr
Geneos Therapeutics
Flerie Invest
United States
Active
Sector
Biotech
InvestorFlerie
Entry
2022
Hold
4yr
GenEP
Angelini Ventures
United States
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
GenePlanet
Lauxera Growth II
Slovenia
Active
Sector
Biotech
InvestorLauxera Capital Partners
Entry
2026
Hold
0yr
General Biotechnologies
Kompas Fund II
United Kingdom
Active
Sector
Biotech
InvestorKompas Vc
Entry
2026
Hold
0yr
GeneratR
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2022
Hold
4yr
Genfit
Finorpa SCR
France
Active
Sector
Biotech
InvestorFinorpa Gestion
Entry
1999
Hold
27yr
Geno
Novo Holdings Bioindustrial Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Glionova AB
HealthCap VI
Sweden
Active
Sector
Biotech
InvestorHealthCap
Entry
2014
Hold
12yr
GlycoSpot
Spring Nordic
Denmark
Active
Sector
Biotech
InvestorSpring Nordic
Entry
2014
Hold
12yr
Gran Lab Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2024
Hold
2yr
GraphTx
Daphni Blue
France
Active
Sector
Biotech
InvestorDaphni
Entry
2026
Hold
0yr
Green Molecular
CRB Bio I
Spain
Active
Sector
Biotech
InvestorCRB Health Tech
Entry
2009
Hold
17yr
Guard Therapeutics
Industrifonden Evergreen
Sweden
Active
Sector
Biotech
InvestorIndustrifonden
Entry
2022
Hold
4yr
Henlez
Eir Ventures I
Denmark
Active
Sector
Biotech
InvestorEir Ventures
Entry
2022
Hold
4yr
HiloProbe
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2018
Hold
8yr
Hornet Therapeutics
4BIO Ventures III
UK
Active
Sector
Biotech
Investor4Bio Partners
Entry
2024
Hold
2yr
Hypesound
Vento Fund II
Italy
Active
Sector
Biotech
InvestorVento
Entry
2025
Hold
1yr
iECURE
Novo Holdings Venture Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
Immuneed
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr
Immunitas Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
5yr
Immunorx Pharma, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
InCarda Therapeutics Inc.
HealthCap VII
United States
Active
Sector
Biotech
InvestorHealthCap
Entry
2018
Hold
8yr
Integrated Dna Technologies
Summit Partners Portfolio
USA
Active
Sector
Biotech
InvestorSummit Partners
Entry
–
Invoke Bio
HCVC Hardware Club Fund II
United States
Active
Sector
Biotech
InvestorElephants & Ventures / Hardware Club
Entry
–
Ionlace
Heartcore Capital Fund IV
Sweden
Active
Sector
Biotech
InvestorHeartcore Capital
Entry
2023
Hold
3yr
Iscaff Pharma
GU Ventures Evergreen
Sweden
Active
Sector
Biotech
InvestorGU Ventures
Entry
2017
Hold
9yr
Iteria
Inveready Biotech III
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2026
Hold
0yr
Izote Biosciences
Nucleus Capital II
United States
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2024
Hold
2yr
JLand Biotech
Evonik Venture Capital
China
Active
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2024
Hold
2yr
KAAPA Biotech
Zintinus Fund I
Finland
Active
Sector
Biotech
InvestorZintinus
Entry
2025
Hold
1yr
KAHR Medical
Flerie Invest
Israel
Active
Sector
Biotech
InvestorFlerie
Entry
2012
Hold
14yr
Karuna Therapeutics
General Atlantic
United States
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Kiin Bio
Heartfelt Fund I
United Kingdom
Active
Sector
Biotech
InvestorHeartfelt
Entry
2025
Hold
1yr
Kromnigon
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2021
Hold
5yr
Kynda Biotech
FoodLabs Fund II
Germany
Active
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Kyron.bio
HCVC Hardware Club Fund II
France
Active
Sector
Biotech
InvestorElephants & Ventures / Hardware Club
Entry
2025
Hold
1yr
Lakepharma
Summit Partners Growth Equity Fund X
USA
Active
Sector
Biotech
InvestorSummit Partners
Entry
–
LAmAb Biologics, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Larq
Health for Life Capital
United States
Active
Sector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Lead Biologics
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2025
Hold
1yr
Leadartis
Sodena Direct
Spain
Active
Sector
Biotech
InvestorSodena
Entry
2021
Hold
5yr
Leal Therapeutics
Dementia Discovery Fund 2
United States
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr